Positive Phase 3 HERIZON-GEA-01 results for Ziihera (zanidatamab-hrii) in first-line HER2-positive (HER2+) gastroesophageal adenocarcinoma (GEA) presented at ASCO GI Up to $440.0 million in milestone ...
Elon Musk has declared that defeating human death through longevity breakthroughs is far more achievable, calling it an ...
Krish S. Krishnan, Chairman and Chief Executive Officer, and Suma M. Krishnan, President of Research and Development, will highlight these updates and Krystal’s strategic vision in a presentation at ...
Minister Dr. Jitendra Singh says India is shifting to genomic healthcare. Through the 2021 Rare Disease Policy, the nation is ...
The engagement will explore the use of cellular fermentation to make key starting materials required for pharmaceutical ...
Triple Doctor, Berenika Maciejewicz, serves as the company’s Chief Scientific Advisor merging AI, computational biology ...
An Instagram post about the last two northern white rhinos references a scenario conservationists have warned us about for ...
Moving Biotech receives US FDA’s IND clearance for 4P004; strengthens its position as a leading innovator in disease-modifying osteoarthritis therapeutics: Lille, France Saturd ...
Dr Yajulu Medury, Vice Chancellor, Mahindra University, outlines how universities are aligning education with Industry 4.0 ...
The team brings a strong balance of scientific and commercial expertise, has built a unique data foundation with a ...
Massachusetts research labs recovered most of the federal funding that the Trump administration slashed early last year but ...
Together with cash on hand, the fully leveraged facility extends Aptevo's funding runway into 2029, enabling achievement of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results